• M3CRC Gut Health Screening _NON-INVASIVE colorectal cancer risk prediction test
  • Faecal “bacterial gene markers” test (M3) was developed by the Faculty of Medicine at The Chinese University of Hong Kong.


    Clearbridge Medical M3CRC Gut Health Screening (NON-INVASIVE colorectal cancer risk prediction test)

    • M3CRC is the world's only non-invasive colorectal cancer risk prediction test that defects non-advanced adenoma, which is designed for people who have concerns about gut health. The Programme adopts the world’s first faecal “bacterial gene markers” test (M3)* developed by the Faculty of Medicine at The Chinese University of Hong Kong. This non-invasive test can detect colorectal cancer (CRC) early and can also be applied to the prediction of polyp recurrence.*
    • Easy and convenient: only stool sample is required, 94% sensitivity for CRC
    • Sensitivity for adenoma superior to currently available non-invasive tests
    • Tailored for Asians
    • Doctors to conduct health consultation & Physical examination
    • Medical result report interpretation by doctor
    • Medical report attaches dietary recommendations

Write a review

Note: HTML is not translated!
    Bad           Good

M3CRC Gut Health Screening _NON-INVASIVE colorectal cancer risk prediction test

  • Availability: In Stock
  • HKD: 4,000